ELITE 2020 Sales MVP John Herley of ConnectiveRx

John Herley

SVP Business Development


Above and Beyond the Sales Quota

John Herley started his sales career with one overriding commitment: No matter the competitive stress or institutional pressure to “make the quarterly number,” he would always put his customers’ needs, goals, and pain points first. Always. That singular commitment has been the driving force behind his success as a dynamic biopharma sales professional.

John began his sales career at SDI Health, where he was Rookie of the Year in 2008, was named Regional Sales MVP in 2010, and led new sales from 2008 to 2011.

When SDI was acquired by IMS Health, he took on the role of Solutions Sales Specialist, where he led global sales to a top five pharma client and exceeded all sales and performance goals. After being promoted to Principal at IMS and serving as Subject Matter Expert in Reimbursement and Access, his clients ranged from small biotech firms to Fortune 100 companies.

Since joining ConnectiveRx (then PSKW) in 2012, his penchant for meeting customers’ needs has continued to drive record results. From 2018 to 2019, he led the company in most analytical sales and currently manages ConnectiveRx’s largest copay program. He expanded ConnectiveRx’s footprint for one key client from a single brand in 2014 to an exclusive copay provider relationship in 2020. John has been the first to sell many of ConnectiveRx’s new-to-market solutions and he pioneered the company’s first enterprise hub program.

“John goes beyond the transactional mindset to build real and lasting customer relationships by deploying solutions grounded in actionable analytics,” says Frank Dana, Chief Commercial Officer, ConnectiveRx. “Many of his programs have helped expand customers’ market share significantly, and new prescriptions often grow exponentially. In every case, data-based insights and analytics are the highlights of John’s service. And his consultative approach doesn’t end with the sale; he continues to strategically analyze his accounts to ensure programs are optimized to meet clients’ and patients’ objectives. With this kind of focus, it’s no surprise that John consistently exceeds his sales quota and is a recognized leader in our business development organization!”


You May Also Like

PM360 2018 Innovative Product Veeva Nitro from Veeva Systems

Veeva Nitro Veeva Systems Andy Fuchs, Sr. Director of Commercial Strategy andy.fuchs@veeva.com While artificial ...

Movers and Shakers May 2020

Ex-Vaccine Veteran Returns to WHO to Battle COVID-19 Andrew Witty spent 10 years as ...

PM360 2021 Trailblazer Awards Consumer Website/Online Initiative Silver Winner Amgen and EMCAY

“EVEN THE ODDS” (Amgen, EMCAY) Multiple Myeloma is the most common blood cancer among ...